Logo of Newton Katip Çelebi

Turkey is a Newton Fund partner country. The Newton-Katip Celebi Fund was named after Katip Celebi, a renowned Ottoman scholar who specialised in history and geography.

Turkey’s economic and social development performance since 2000 has led to increased employment and incomes, making Turkey an upper-middle-income country. However, in the past few years, growing economic vulnerabilities and a more challenging external environment have threatened to undermine those achievements. Poverty is still an important challenge and new challenges have emerged, such as the need to manage the social inclusion of 4 million refugees.

0 million (total population)
0 % of GDP (research & development expenditure 2014-18)
0 % seats held by women in deliberative bodies of local government in 2019

Priorities for Turkey

These are mutually identified priorities between the UK and Turkey. Priorities may not cover everything we currently fund and may evolve over time to ensure they continue to meet our shared objectives.
01
Advanced manufacturing
02
Agri-food
03
Basic sciences
04
Environmental science
05
Health
06
Information and communication
07
Social sciences
FEATURED STORY

Uncovering plastic’s harmful impact on human health

Turkey discards millions of tonnes of plastic waste every year. Over time these plastics leak harmful chemicals into the environment. This UK-Turkey collaboration has revealed how endocrine disrupting chemicals (EDCs) used in everyday plastic food containers and food packaging are damaging the...

Local funding partners

Each Newton Fund partnership is unique. UK and international partners work together to devise and deliver Newton Fund programmes.

Turkiye Bilimsel ve Teknolojik Arastirma Kurumu

Visit TUBITAK

OPPORTUNITIES

Funding opportunities

Information about our schemes, funding guidance, what's on offer and our partner matching service.

Related articles

Newton Fund in Turkey is delivering a series of ‘Newton For Climate’ webinars with the aim of showcasing the impacts and successes of Newton projects in Environmental Studies. The UK will host...

11 October 2021
Researchers collaborating

Ellie Anghileri –  The year 2020 marked the 25th Anniversary of the Beijing Declaration and Platform for Action, the most progressive blueprint yet for advancing the rights of women and...

23 February 2021
Dr Ozge Akbulut and researchers

Breast cancer is the most common cancer in women worldwide. Surgical treatment of breast cancer can have a significant impact on a woman’s body and self-identity. A patient’s physical and...

20 November 2020

Contact the Newton-Katip Celebi Fund team

If you are interested in learning more about Newton-Katip Celebi Fund please get in touch with our local team.

Pinar Celikcan

Newton Fund Programme Manager

GCRF Logo

Turkey’s economic and social development performance since 2000 has led to increased employment and incomes, making Turkey an upper-middle-income country. However, in the past few years, growing economic vulnerabilities and a more challenging external environment have threatened to undermine those achievements. Poverty is still an important challenge and new challenges have emerged, such as the need to manage the social inclusion of 4 million refugees.

0 million (total population)
0 % of GDP (research & development expenditure 2010-17)
0 % seats held by women in deliberative bodies of local government in 2019
OPPORTUNITIES

Funding opportunities

Information about our schemes, funding guidance, what's on offer and our partner matching service.

Related articles

Secure food production for present and future generations relies on healthy agricultural...

11 October 2022

By Dr. Ala’a Alshdiefat – The UK aims to reduce all greenhouse gas emissions to net zero by 2050. Net Zero means reducing emissions to their lowest amount through energy efficiency measures...

27 September 2022

Infectious diseases are responsible for nearly 70% of deaths in Africa each year. Globally, drug-resistant infections are on the rise, making the search for new and effective medicines increasingly...

24 November 2022